An epidemiological study of symptomatic paroxysmal atrial fibrillation in northwest Greece

Europace

Volumn 1, Issue 4, 1999, Pages 226-233

  Goudevenos, J A ^a   Vakalis, J N ^a   Giogiakas, V ^a   Lathridou, P ^a   Katsouras, C ^a   Michails, L K ^a   Sideris, D A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Epidemiology; Paroxysmal atrial fibrillation

Indexed keywords

ADULT; AGED; ARTICLE; ECHOGRAPHY; FEMALE; GREECE; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; ATRIAL FIBRILLATION; FEMALE; GREECE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0033206836     PISSN: 10995129     EISSN: None     Source Type: Journal    
DOI: 10.1053/eupc.1999.0059     Document Type: Article

References (28)

1. Prystowsky EN, Benson DW, Fuster V et al. Management of patients with atrial fibrillation. A statement for healthcare professionals. From the subcommittee on electrocardiography and electrophysiology, American Heart Association. Circulation 1996; 93: 1262-77.
2. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: The Framingham study. N Engl J Med 1982; 306: 1018-22.
3. Wolf PA, Abbott RD, Kannel WB. Atrial Fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 1991; 22: 983-8.
4. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994; 271: 840-4.
5. Kannel WB, Abbott RD, Savage DD. Coronary heart disease and atrial fibrillation: the Framingham study. Am Heart J 1983; 106: 389-96.
6. Gersh BJ. The epidemiology of atrial fibrillation and atrial flutter. In: DiMarco JP, Prystowsky EN, eds. Atrial arrhythmias: the state of the art. Armonk, NY: Futura Publishing Co, 1994; 1-22.
7. Aboaf AL, Wolf PS. Paroxysmal atrial fibrillation. A common but neglected entity. Arch Intern Med 1996; 146: 362-7.
8. Pritchett ELC. Editorial comments. In: DiMarco JP, Prystowsky EN, eds. Atrial arrhythmias: the state of the art. Armonk, NY: Futura Publishing Co, 1994: 23-29.
9. Laupacis A, Albers G, Dunn M, Feinberg W. Antithrombotic therapy in atrial fibrillation. Chest 1992; 102(Suppl 4): 426S-433S.
10. Page RL, Wilkinson WE, Clair WK, McCarthy EA, Pritchett ELC. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994; 89: 224-7.
11. Gallacher MM, Camm AJ. Classification of Atrial Fibrillation. PACE 1997; 20: 1603-5.
12. Pritchett ELC. The case for just plain 'Atrial Fibrillation'. PACE 1998; 21: 637-40.
13. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Arch Intern Med 1995; 155: 469-73.
14. Werkö L. Atrial fibrillation: introduction In: Olsson BS, Allessie MA, Campbell RWF eds. Atrial Fibrillation. Mechanisms and Therapeutic Strategies. Armonk, NY: Futura Publishing Co, 1994; 1-14.
15. Narayan SM, Cain ME, Smith JM. Atrial fibrillation. Lancet 1997; 350: 943-50.
16. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM for the CHS Collaborative Research Group. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994; 74: 236-41.
17. Krahn AD, Manfreda J, Täte RB, Mathewson FAL, Cuddy TE. The natural history of atrial fibrillation: Incidence, risk factors and prognosis in the Manitoba Follow-up Study. Am J Med 1995; 98: 476-84.
18. Onundarson PT, Thorgeirsson G, Jonmundsson E, Sigfusson N, Hardarson Th. Chronic atrial fibrillation-epidemiologic features and 14 year follow-up: A case control Study. Eur Heart J 1987; 8: 521-7.
19. Takahashi N, Seki A, Imataka K, Fujii J. Clinical features of paroxysmal atrial fibrillation. Jpn Heart J 1981; 22: 143-9.
20. Suttorp MJ, Kingma JH, Koomen EM, Hof AV, Tijssen JGP, Lie KI. Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. Am J Cardiol 1993; 71: 710-3.
21. Clementy J, Dulhoste MN, Laiter C, Denjoy I, Dos Santos P. Flecainide acetate in the prevention of paroxysmal atrial fibrillation: a nine-month follow up of more than 500 patients. Am J Cardiol 1992; 70 (Suppl): 44A-49A.
22. Forfar JC, Toft AD. Thyrotoxic atrial fibrillation: an underdiagnosed condition? BMJ 1982; 285: 909-10.
23. Presti CF, Hart RG. Thyrotoxicosis, atrial fibrillation and embolism, revisited. Am Heart J 1989; 117: 976-97.
24. Koskinen P, Kupari M. Alcohol and cardiac arrhythmias. Patients with unexplained tachyarrhythmias; should be questioned about their drinking. BMJ 1992; 304: 1394-5.
25. Murgatroyd FD, Camm AJ. Atrial arrhythmias. Lancet 1993; 341: 1317-22.
26. Kopecky SL, Gersh BJ, McGoon MD et al. The natural history of lone atrial fibrillation: a population-based study over three decades. N Engl J Med 1987; 317: 669-74.
27. Lip GYH, Beevers G. History, epidemiology and importance of atrial fibrillation. BMJ 1995; 311: 1361-3.
28. Brand FN, Abbott RD, Kannel WB et al. Characteristics and prognosis of lone atrial fibrillation: 30-year follow-up in the Framingham study. JAMA 1985; 254: 3449-53.